Since the beginning of my academic and clinical career over 40 years ago, my primary focus has been bone marrow transplantation and immunotherapeutic approaches for the treatment of hematological malignancies. My recent research interests include developing novel treatment strategies for hematological malignancies, such as CAR T-cell therapy, and improving outcomes after hematopoietic stem cell transplantation (HSCT).